In contrast, lymphomas with dual MYC and BCL6 rearrangements represent a more diverse group and have variable gene expression profiles and mutational spectra, making them markedly different from DLBCL/HGBL-MYC/BCL2 [21]. The gene discussed is MYC; the disease is lymphoma.